Genital Chlamydia
In 2015, the rate of genital chlamydia increased to 304.0 per 100,000 population, continuing the overall provincial trend of a steady increase since 1998.  The highest rates were in Vancouver, Northwest, and Northern Interior Health Service Delivery Areas.  Females continue to have higher rates of genital chlamydia infection compared to males.  The highest rates were among young adults aged 20-29 years followed by adolescents aged 15-19 years.  In 2015, there were 166 extra-genital infections identified and 3 perinatally-acquired infections.  The number of LGV cases remains higher than historic levels. In 2015, the number of LGV cases reached an all-time high of 42 cases, all were among men who have sex with men, and many of whom are co-infected with HIV.
Genital Gonorrhea
In 2015, the provincial rate of genital gonorrhea increased to 67.4 per 100,000 population, continuing an overall steady increase since 1998.  The highest rates were in Vancouver, Northwest, and Fraser East Health Service Delivery Areas.  Males have higher rates of infection compared to females and in 2015, rates among both males and females increased to an all-time high.  The highest rates of infection were among males aged 25-29 years and among females aged 20-24 years.  In 2015, there were 505 extra-genital infections identified and one perinatally-acquired infection.  Analysis of recent gonorrhea antimicrobial resistance trends in BC demonstrates a reduction in the proportion of isolates with reduced susceptibility to cefixime and ceftriaxone since 2011.
Pelvic Inflammatory Disease and Ectopic Pregnancy
In 2015, the rate of physician billings and hospital admissions for women related to pelvic inflammatory disease was stable or decreased which is consistent with the overall decline in this potential complication of chlamydia or gonorrhea infection over the past two decades. While hospitalizations of women related to ectopic pregnancy have shown a similar trend, the number of physician billings has shown a small but steady increase since 2003 in BC.
Infectious Syphilis
In 2015, the provincial rate of infectious syphilis increased to 16.2 per 100,000 population, continuing a steady increase since 2011.
 The highest rates of infection were in Vancouver and South Vancouver Island Health Service Delivery Areas.  In 2015, over 95% of cases were male, with highest rates observed in males aged 25-29 years. A slight increase in female cases was identified in 2015.  The majority of cases in 2015 were among people identified as Caucasian (48%).  Men who have sex with men (MSM) continue to comprise the greatest number of new infectious syphilis cases in BC (84% in 2015). Among MSM cases where HIV status is known, 51% were co-infected with HIV. Genital chlamydia is the most commonly reported sexually transmitted infection in BC. As the majority of chlamydia infections are asymptomatic, the reported number of chlamydia infections is only a portion of the total population burden. If untreated, genital chlamydia may lead to complications such as pelvic inflammatory disease (a major cause of infertility, ectopic pregnancy, and chronic pain) in women and epididymo-orchitis in men.
Mirroring the national trend, genital chlamydia rates have steadily increased from 1998 to 2015 following a decline in the early 1990s ( Figure 2 ). In 2015, the rate of genital chlamydia for BC increased to 304.0 (14,245 cases) from 288.3 (13,352 cases) per 100,000 population in 2014. The highest rates of genital chlamydia were in Vancouver Coastal and Northern Health Authorities ( Figure 3 ). Rates among Health Service Delivery Areas varied with the highest rates in Vancouver, Northwest and Northern Interior, and the lowest rates in Kootenay Boundary, Fraser East and Fraser South ( Figure 1 ).
Similar increases in chlamydia infections have been observed in high income countries around the world. 1, 2 There are multiple reasons for this increase, including increases in the sensitivity of laboratory tests and uptake of testing (e.g., the greater acceptability of urine-based tests among men) as well as provider screening practices. There may also be a paradoxical effect in which improvements in early screening and treatment for chlamydia over the past decades have resulted in individuals being less likely to develop full immunity thus consequently more susceptible to re-infection (known as the "arrested immunity" hypothesis 3, 4 ). While data on population trends in sexual behaviour is not available for BC, it is possible that changes in behaviour, such as decreased condom use, may also be contributing to increasing chlamydia incidence.
Females continue to have approximately 1.6 times the diagnosis rate compared to males. The rate for females in 2015 increased to 369.7 (8,724 cases) from 352.8 (8, 225 cases) per 100,000 population in 2014 ( Figure 4 ). The greater number of infections among females is partially due to routine screening performed at the time of visits that were for other reasons (e.g., pap testing or contraception counselling). In 2015, the highest rates of chlamydia were among young adults aged 20-29 years followed by adolescents aged 15-19 years ( Figure 6 ), driven primarily by the high rates of infection among young females. For females, the rates for all age groups increased from 2014 to 2015 ( Figure 7 ). Males aged 20-29 years had the highest chlamydia rates in 2015 compared with other age groups ( Figure 8 ). 6  Total  7  6  4  11  8  7  9  11  25  40  Male  Throat  4  1  6  2  7  1  51  42  80  109  Eye  8  5  5  5  5  5  3  2  8  11  Lung  0  1  0  0  0  0  0  0  0  0  Other *  0  0  2  0  3  5  2  2  3  4  Total  12  7 Gonorrhea infections may be asymptomatic or the symptoms may be mild, and as a result, the reports of diagnosed infections are only a portion of the total population burden. As with chlamydia, genital gonorrhea if untreated can lead to pelvic inflammatory disease (and associated complications) in females. An individual infected with gonorrhea is also at increased risk of acquiring HIV. 9, 10 Overall since 1998, the provincial genital gonorrhea rate in BC has increased steadily, consistent with national rates ( Figure 13 ). However, the genital gonorrhea rate in BC increased over 70% to 67.4 (3,160 cases) in 2015 from 38.9 (1,803 cases) per 100,000 population in 2014. The highest rate was in the Vancouver Coastal Health Authority ( Figure 14 ). Rates among Health Service Delivery Areas vary with the highest rates in Vancouver, Northwest and Fraser East, and the lowest rates in East Kootenay, Richmond and North Vancouver Island ( Figure 12 ). Reasons for the increase in gonorrhea rates in 2015 are still under investigation. Preliminary findings suggest that a shift in strain-type may account for some of this increase, as well as increased testing. The BCCDC is working in partnership with the BCCDC Public Health Laboratory (BCCDC PHL), National Microbiology Laboratory (NML) and Public Health Agency of Canada (PHAC) to understand the epidemiology of gonorrhea.
Males continue to have a rate about two times greater than females ( Figure 15 ). Since 2006, male and female gonorrhea rates have been steadily increasing. In 2015, the rates among both males and females increased to a 25-year high of 88.8 (2,065 cases) among males and 46.2 (1,089 cases) among females per 100,000 population.
Similar to trends from 2006 to 2014, in 2015, the highest rates of gonorrhea were among those aged 20-29 years ( Figure 17 ). In 2015, the highest rates among males were in those aged 25-29 years (445 cases, 280.7 per 100,000 population) and among females in those aged 20-24 years (301 cases, 194.8 per 100,000 population) ( Figure 16 ).
Gonorrhea is more likely to be concentrated in sexually active networks and it is likely that the higher rates of gonorrhea in males is, in part, due to higher rates of gonorrhea among gay, bisexual, and other men who have sex with men (MSM). While provincial surveillance data does not permit identification of MSM cases, this has been observed in other jurisdictions. 11, 12 Genital Gonorrhea by Region, Gender, and Age STI in British Columbia: Annual Surveillance Report 
Extra-genital Gonorrhea
In 2015, 505 cases were identified (41 females, 464 males) which was an increase from 366 cases (22 females, 344 males) in 2014. As screening for gonorrhea infections at extra-genital sites is not routine practice, these findings are strongly influenced by provider testing practices, including increases in screening in the past few years. Of the 1,678 cases diagnosed from 2006 to 2015, cases were identified in the throat ( Total  42  47  43  51  63  100  159  186  344  464  Throat  57  61  44  53  63  108  165  213  353  491  Eye  0  2  2  5  5  0  1  2  7  11  Other *  1  4  0  1  5  5  2  2  6  3  DGI **  0  0  2  1  0  0  2  1  0  0  Total  58  67  48  60  73  113  170  218 366 505 * Other -superficial wound, sternoclavicular synovium, synovium joint fluid, abscess, blood, and elbow ** DGI -disseminated gnococcal infection Total reports for BC is the sum of the following genders: female, male, transgender, and gender unknown 
Gonorrhea Antimicrobial Resistance
Treatment of gonorrhea has long been challenged by the bacterium's ability to acquire resistance to multiple classes of antibiotics. Historically, effective antibiotics -penicillin, doxycycline, and ciprofloxacin -can no longer be used successfully against gonorrhea, leaving few remaining options. BC treatment guidelines currently recommend third-generation cephalosporins for the treatment of gonorrhea: injectable ceftriaxone (250mg) or oral cefixime (800mg), co-treated with 1g of azithromycin. 13 Recent international surveillance data and case reports however, suggest that susceptibility of gonorrhea to these current first-line treatments is also now threatened. 14, 15 In this context, local surveillance is critical.
The BCCDC Public Health Laboratory (PHL) routinely tests N. gonorrhoeae isolates for susceptibility to a panel of antimicrobial drugs, including cefixime, ceftriaxone, and azithromycin. Data presented here summarize the minimum inhibitory concentration (MIC) of these drugs among isolates from BC. The MIC is the lowest amount of antibiotic required to inhibit growth of the bacterium; a higher MIC means the bacterium is less susceptible to the antibiotic.
A total of 4,180 isolates were tested between 2006 and 2015, representing 24.6% (4,180/16,964) of all gonorrhea cases reported in the province. Fifty percent (2,060/4,180) of isolates tested for drug susceptibility were sampled from the urethra, 25.3% (1,056/4,180) from the rectum, 12.1% (506/4,180) from the cervix, and 12.4% (519/4,180) from the throat.
Since 2006, 0.5% (21/4,180) of isolates showed an MIC ≥0.25 µg/mL to cefixime. Fortunately, no isolate was fully resistant to cefixime or ceftriaxone 16 and no treatment failures were reported in BC during this period ( Figure 21 ). The increasing trend in percentage of isolates with elevated MIC (i.e., reduced susceptibility) to cefixime or ceftriaxone observed in 2006-2010 reversed in 2011-2015. Similarly, the increasing trend in percentage of isolates with elevated MIC to azithromycin 17 in 2006-2011 reversed in 2012-2015.
The decline observed in 2011-2015 for reduced susceptibility to cefixime or ceftriaxone among tested isolates is encouraging and, may in part be due to changes in the Canadian and provincial gonorrhea treatment guidelines to more effective regimens (i.e., increased cefixime dosage or improved medication adherence due to single dosage). These trends will be closely monitored in order to inform the future evolution of gonorrhea treatment recommendations. The continued threat of emerging resistance reinforces the need for STI prevention and control measures such as increased testing for gonorrhea, partner testing and treatment of gonorrhea, and tests of cure, as well as the need for antibiotic stewardship to ensure effective treatments for bacterial infections. In BC, steady declines in physician billings and hospital discharges related to PID have been observed over time. Rates in hospital discharges for EP have shown a similar trend although physician billings for EP have increased slightly in recent years. Despite increasing rates of chlamydia and gonorrhea infections, PID has been declining. This paradoxical trend may be a result of targeted screening programs that have led to earlier diagnosis and treatment of chlamydia and gonorrhea that may reduce the probability of complications such as PID and EP.
Pelvic Inflammatory Disease
In 2015, the rate of physician billings related to PID decreased slightly to 221.7 (2,031 physician billings) from 223.8 (2,043 physician billings) per 100,000 women aged 15-44 years in 2014 ( Figure 22 ). Rate of hospital discharges related to PID also show a decrease to 25.1 (230 hospital discharges) in 2015 from 29.8 (272 hospital discharges) per 100,000 women aged 15-44 years in 2014 ( Figure 23 ).
Ectopic Pregnancy
The The initial symptoms of syphilis may not always be recognized and without treatment individuals generally enter a prolonged asymptomatic phase. Individuals can still however, be infectious despite not having any symptoms. Syphilis infection can lead to serious complications, including cardiovascular and neurologic disease, and may be fatal.
Following a decline in rates in BC in the early 1990's, infectious syphilis (i.e., primary, secondary, and early latent stages) began to re-emerge in BC starting in 1997, corresponding to a series of outbreaks in different populations. While provincial trends had been decreasing in 2009-2010, infectious syphilis rates began to increase in 2011 and this became more evident in 2012-2013. In BC, the rate of infectious syphilis increased in 2015 to 16.2 (761 cases) from 11.9 (549 cases) per 100,000 population in 2014 ( Figure 24 ). The highest rate of infectious syphilis was in the Vancouver Coastal Health Authority ( Figure 26 ). Across Health Service Delivery Areas, the highest rates were in Vancouver and South Vancouver Island ( Figure 25 ).
The majority of infectious syphilis cases in BC are male ( Figure 27 ). Although male infectious syphilis rates decreased in 2009-2010, male infectious syphilis rates have since risen to 31.5 (732 cases) per 100,000 population in 2015. The increase in cases among males was observed in all age groups. Since 2014, the highest rates of syphilis was among males 25-29 years old, followed closely by males 30-39 years old ( Figure 31 ). In 2015, the rate of infectious syphilis among females was 1.2 (29 cases), a slight increase from 1.0 (24 cases) per 100,000 population in 2014 ( Figure 27 ).
In 2015, 628 cases (82.5% of all cases) reported sexual (including anonymous) partners while the remaining cases (133 cases, 17.5%) provided no information regarding their sexual partners or were lost to follow-up. Of these 628 cases, 465 cases (74.0%) reported 2,861 sexual partners (notifiable and anonymous); 178 cases (28.3%) reported anonymous partners. Most of the cases (491 cases, 78.2%) stated they would notify their sexual partners themselves. In males, almost half of cases (365 cases; 49.9%) in 2015 were among people who identified as Caucasian (Table 34 ). In comparison, most females (5 cases, 17.2%) in 2015 identified as Aboriginal however, the trends are highly variable due to the small number of female cases each year (29 cases in 2015) (Table 33 ). 
Infectious syphilis case reports in BC and

Percentage of infectious syphilis case reports in BC by ethnicity -male, 2006 to 2015
Infectious syphilis case reports among First
Infectious Syphilis by Exposure Category
Gay, bisexual, and other men who have sex with men (MSM) continue to comprise the greatest number of infectious syphilis cases in BC ( Figure 37 ). HET  27  14  14  18  11  7  18  24  29  30  Outside  6  6  1  2  3  1  0  3  4  1  Other/UNK  0  1  1  1  1  2  4  8  13  19  MSM  4  7  6  7  3  13  10  13  22  42  Street/STW  0  3  3  4  0  0  0  0  0  0  HET  8  7  2  7  1  3  2  6  8 157  174  229  146  115  154  310  476  466  642  Street/STW  99  65  53  20  12  9  14  14  6  4  HET  63  50  37  46  21  23  37  51  51  82  Outside  10  9  6  3  5  1  2  5  8  1  Other/UNK  2  3  3  2  1  4  6  12  18 Gay, bisexual, and other men who have sex with men (MSM) continue to be disproportionally affected by the current infectious syphilis epidemic in BC, constituting 84.4% (642/761 cases) of all cases in 2015 ( Figure 37 ). The number of infectious syphilis cases among MSM has been steadily increasing since 2011. This is similar to the profile of syphilis epidemics in other Canadian provinces 20 , the US 21 , and several European countries 22 where syphilis cases were also predominantly among MSM and trends are increasing.
There were 642 cases among MSM in 2015, 21.3% (137 cases) were diagnosed with primary syphilis, 16.0% (103 cases) with secondary syphilis, and 62.6% (402 cases) were diagnosed with early latent infection. The proportion of infectious syphilis cases among MSM in the early latent stage of infection has steadily increased over time which may reflect increased syphilis testing. In 2015, 165 (25.7%) MSM cases had a prior syphilis diagnosis within the past five years, highlighting the importance of repeat infections in the current epidemic. 23 Despite recent increases in the number of annual cases, the characteristics of MSM with syphilis have remained similar over time. The number of cases increased for all age groups in 2015 ( Figure 41 ) and the mean age of MSM diagnosed with syphilis was 40 years (range 17-82 years).
In 2015, the majority of cases resided in the Lower Mainland with 71.7% (460 cases) residing in Vancouver and 16.4% (105 cases) in Fraser. As in previous years, the majority of cases in 2015 were among Caucasian (354 cases, 55.1%), Asian (52 cases, 8.1%), and Hispanic (39 cases, 6.1%) men (Table 40) .
Living with HIV continues to be an important risk factor for acquiring infectious syphilis. In 2015, of the MSM cases with a known HIV status (620 cases), 51.3% (318 cases) were living with HIV at the time of their syphilis diagnosis which is a decrease from 2014 (265/447 cases, 59.3%) ( Figure 42 ). The possible roles of core sexual networks and the biological synergy between HIV and syphilis are important areas of study which may help explain this trend. Coordinated public health follow-up, promotion of condom use, partner notification, and partner testing for all syphilis cases remain the cornerstone to controlling the syphilis epidemic for MSM in BC as do efforts to raise awareness among MSM. Given the continued increase of syphilis cases, the enhancement of ongoing programs and development of new syphilis control interventions for MSM remain a priority in BC. 
Percentage of infectious syphilis case reports among MSM in BC by ethnicity, 2006 to 2015
Stage of Infection at Time of Syphilis Diagnosis
There have been slow changes in the proportion of infectious syphilis cases by stage of infection (i.e., primary, secondary, and early latent) over time. Most notably, the proportion of cases that are early latent syphilis has been increasing over time. This may reflect a greater uptake of syphilis testing or screening as people with syphilis infections in the early latent stage of infection are typically asymptomatic. In 2015, the proportion of cases that are early latent decreased slightly to 64.1% (488 cases) from 65.2% (358 cases) in 2014 ( Figure 43 ). This increase may be a year-to-year variation.
From 2006 to 2015, 5.2% (195/3,759 cases) of infectious syphilis cases were also diagnosed with neurosyphilis. Neurosyphilis is commonly considered to be indicative of an advanced syphilis infection but can sometimes occur at an early stage of infection. 
Maternal and Early Congenital Syphilis
Infectious syphilis acquired prior to or during pregnancy can be vertically transmitted to the infant which can have serious consequences, including infant death. Accordingly, prenatal screening for syphilis is recommended for all pregnant women in BC, as treatment will reduce the risk of transmission to or complications in infants.
In 2015, 51,131 syphilis tests were conducted as part of prenatal screening. Overall, the number of syphilis tests performed prenatally each year in BC is increasing slightly. There were no cases of congenital syphilis identified in BC in 2015 ( Figure 44 ). In 2015, eleven maternal syphilis cases were reported whereas six cases were reported in 2014. We would like to acknowledge the contributions of our many partners who without their support this report would not have been possible. Technical Appendix
STI in
Data Limitations
There are several key limitations to surveillance data which are important to understand in order to interpret surveillance data appropriately. 
Infectious Syphilis
Infectious syphilis is a complex sexually transmitted infection that has a highly variable clinical course. Three stages of syphilis, primary, secondary and early latent, comprise infectious syphilis. Classification by a clinician with expertise in syphilis may take precedence over the following case definitions developed for surveillance purposes.
Primary Syphilis: Current clinical presentation compatible with primary syphilis (e.g., one or more ulcers/chancres), and one of the following:
 Identification of T. pallidum in clinical specimens (e.g., from chancre, regional lymph node) by dark field microscopy, direct fluorescent antibody, or nucleic acid amplification test (NAAT), or  Reactive serology (treponemal, regardless of non-treponemal serology reactivity) in individuals with no previous history of syphilis, or  Significant (i.e., four-fold or greater) increase in titre over the last known nontreponemal test.
Secondary Syphilis: Clinical presentation compatible with secondary syphilis (e.g., rash, fever, malaise, lymphadenopathy, mucus lesions, condyloma lata, alopecia, meningitis, headaches, uveitis, retinitis, recent hearing impairment), and one of the following:
 Identification of T. pallidum in clinical specimens (e.g., from chancre, regional lymph node) by dark-field microscopy, direct fluorescent antibody, or nucleic acid amplification test (NAAT), or When an individual is diagnosed with a reportable STI, the care provider completes a case report form (Health 208 form) then forwards it to BCCDC where the information is entered into the provincial STI database. Public health clinics with access to the provincial STI database directly enter the information for their newly diagnosed individuals.
Pelvic Inflammatory Disease and Ectopic Pregnancy Data
The diagnoses of pelvic inflammatory disease (PID) and ectopic pregnancy (EP) are captured in the Discharge Abstract Database (DAD) and the Medical Service Plan (MSP) payment database maintained by the BC Ministry of Health. The DAD includes data on patient discharges and day surgeries directly from hospitals in BC, including all known facilities for acute care and day surgery, and most facilities for LGV serovar testing via the BCCDC PHL. In addition, since 2012, clinics operated by the BCCDC have been routinely screening for C. trachomatis from extra-genital sites among those reporting behaviours that may put them at risk for pharyngeal or rectal infections.
The BCCDC PHL performs approximately 15-20% of all gonorrhea testing in the province, receiving specimens predominantly from Provincial Sexually Transmitted Infection Clinic sites operated by the BCCDC, from regional public health, youth, reproductive and sexual health clinics, and from hospitals throughout the province. At the BCCDC PHL, gonorrhea may be detected by nucleic acid amplification testing (NAAT) or conventional culture diagnostic methods. Culture testing is preferentially used for rectal and pharyngeal specimens and for all specimens from contacts to gonorrhea as well as patients who are symptomatic, not responding to treatment, or presenting for treatment after an initial NAAT-positive test. Antimicrobial susceptibility testing is routinely performed for all N. gonorrhoeae isolated by culture from clinical specimens. The BCCDC PHL additionally receives gonorrhea isolates forwarded for susceptibility testing from community or hospital-based laboratories in BC. Antimicrobial susceptibility testing is by E-test (bioMerieux) and data are analyzed by isolate.
